SELIMETRY—a multicentre I-131 dosimetry trial: a clinical perspective

Treatment options for patients with thyroid cancer that is no longer sensitive to iodine therapy are limited. Those treatments which currently exist are associated with significant toxicity. The SELIMETRY trial (EudraCT No 2015-002269-47) aims to investigate the role of the MEK inhibitor Selumetinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadsley, Jonathan, Gregory, Rebecca, Flux, Glenn, Newbold, Kate, Du, Yong, Moss, Laura, Hall, Andrew, Flanagan, Louise, Brown, Sarah R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology. 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605100/
https://www.ncbi.nlm.nih.gov/pubmed/28291381
http://dx.doi.org/10.1259/bjr.20160637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605100/
https://www.ncbi.nlm.nih.gov/pubmed/28291381
http://dx.doi.org/10.1259/bjr.20160637

Ejemplares similares